intracranial hemorrhage associated with Aptivus (tipranavir)

Health Canada is warning of intracranial hemorrhage associated with Aptivus (tipranavir).

Aptivus is given in combination with low-dose ritonavir for patients who are resistant to multiple protease inhibitors.

There are now reports that Aptivus patients have suffered intracranial hemorrhage...and some have died.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote